ActiveMax® Human CD19 μBeads, premium grade (for cells)

DMF
Super stable version MBS-C035 is now available.
1/7
+4 View all
Cat. No. / Size
Price
Availability
Qty
MBS-C002-2.5mg
$2,390.00
In Stock - Delivery in 1-2 business days
MBS-C002-10mg (2.5mg X 4)
$5,875.00
In Stock - Delivery in 1-2 business days
MBS-C002
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Product Information
Product
Size
Amount
ActiveMax® Human CD19 μBeads, premium grade (for cells)
2.5 mg
2.5×10⁷ beads
ActiveMax® Human CD19 μBeads, premium grade (for cells)
10 mg (2.5 mg×4)
1.0×10⁸ beads
Product Show
CD19 PRODUCT SHOW

This product can be directly isolated using conventional column-free magnetic stand (eg. Cat. MB-01/ MB-02/ MB-03/ MB-04). Please note that due to its micron-scale size, it is not compatible with commercially available column-based (M/D/L) magnetic separation systems.

Features
  • FDA DMF filed
  • Sterility
  • Endotoxin content ≤0.002 EU/μg
  • Mycoplasma
  • Batch-to-batch consistency
Product Description

ActiveMax® Human CD19 μBeads, premium grade (for cells) are uniform, superparamagnetic beads of 5.5 µm in diameter immobilized with Human CD19 protein expressed from human 293 cells (HEK293) and contains AA Pro 20 - Lys 291 (Accession # P15391-1).
ActiveMax® Human CD19 μBeads, premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.

Application

ActiveMax® Human CD19 μBeads, premium grade (for cells) are designed to stimulate in vitro CD19-specific CAR-T cells or UCAR-T cells, similar to the tumor cell lines that express human CD19 antigen. It can be used as follows:
Evaluating the characteristics of CAR-T cells or UCAR-T cells.
In vitro expansion of CD19-specific CAR-T cells or UCAR-T cells.
In vitro enrichment of CD19-specific CAR-T cells or UCAR-T cells.

Reconstitution

See Certificate of Analysis (CoA) for detailed instruction.

Storage

This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.

Please protect from light and avoid repeated freeze-thaw cycles.Immediate use after reconstitution is highly recommended.

Sterility

Negative

Endotoxin

Less than 0.002 EU per μg by the LAL method / rFC method.

Mycoplasma

Negative

Important Note

This product is for research use only and not intended for therapeutic or in vivo diagnostic use.

Formulation

Lyophilized in PBS with 0.1% HSA,pH 7.4. Trehalose is added as protectant before lyophilization.